Kato, M. Editorial Comment on “Efficacy of pembrolizumab plus lenvatinib as first‐line treatment for metastatic renal cell carcinoma with multiple brain metastases”. Wiley.
Chicago Style (17th ed.) CitationKato, Manabu. Editorial Comment on “Efficacy of Pembrolizumab Plus Lenvatinib as First‐line Treatment for Metastatic Renal Cell Carcinoma with Multiple Brain Metastases”. Wiley.
MLA (9th ed.) CitationKato, Manabu. Editorial Comment on “Efficacy of Pembrolizumab Plus Lenvatinib as First‐line Treatment for Metastatic Renal Cell Carcinoma with Multiple Brain Metastases”. Wiley.
Warning: These citations may not always be 100% accurate.